Association between De Ritis ratio (aspartate aminotransferase/alanine aminotransferase) and oncological outcomes in bladder cancer patients after radical cystectomy

被引:46
作者
Ha, Yun-Sok [1 ,2 ]
Kim, Sang Won [1 ,2 ]
Chun, So Young [1 ,2 ]
Chung, Jae-Wook [1 ,2 ]
Choi, Seock Hwan [1 ,2 ]
Lee, Jun Nyung [1 ,2 ]
Kim, Bum Soo [1 ,2 ]
Kim, Hyun Tae [1 ,2 ]
Yoo, Eun Sang [1 ,2 ]
Kwon, Tae Gyun [1 ,2 ]
Kim, Won Tae [3 ]
Kim, Wun-Jae [3 ]
Kim, Tae-Hwan [1 ,2 ]
机构
[1] Kyungpook Natl Univ, Sch Med, Dept Urol, Daegu, South Korea
[2] Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Sch Med, Dept Urol, Daegu, South Korea
[3] Chungbuk Natl Univ, Coll Med, Dept Urol, Cheongju, South Korea
基金
新加坡国家研究基金会;
关键词
Bladder cancer; Prognosis; Survival; De Ritis ratio; PROGNOSTIC-FACTORS; GUIDELINES; CARCINOMA; DIAGNOSIS; MORTALITY; THERAPY; KOREA;
D O I
10.1186/s12894-019-0439-7
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
BackgroundNew biological prognostic predictors have been studied; however, some factors have limited clinical application due to tissue-specific expression and high cost. There is the need for a promising predictive factor that is simple to detect and that is closely linked to oncological outcomes in patients with urothelial bladder cancer (BC) who have undergone radical cystectomy (RC). Therefore, we investigated the clinical prognostic value of the preoperative De Ritis ratio (aspartate aminotransferase/alanine aminotransferase) on oncological outcomes in patients with urothelial BC after RC.MethodsWe retrospectively evaluated clinicopathological data of 118 patients with non-metastatic urothelial BC after RC between 2008 and 2013 at a single center. The association between the De Ritis ratio and clinicopathological findings was assessed. The potential prognostic value of the De Ritis ratio was analyzed using the Kaplan-Meier method, and multivariate Cox analyses were performed to identify the independent predictors of metastasis-free survival, cancer-specific survival, and overall survival.ResultsAccording to the receiver operating curve of the De Ritis ratio for metastasis, we stratified the patients into 2 groups using a threshold of 1.3. A high De Ritis ratio was more likely to be associated with old age and the female sex. Kaplan-Meier estimates revealed that patients with a high De Ritis ratio had inferior metastasis-free survival, cancer-specific survival, and overall survival outcomes (P=0.012, 0.024, and 0.022, respectively). Multivariate analysis revealed that a high De Ritis ratio was an independent prognostic factor for metastasis (hazard ratio [HR], 2.389; 95% confidence interval [CI], 1.161-4.914; P=0.018), cancer-related death (HR, 2.755; 95% CI, 1.214-6.249; P=0.015), and overall death (HR, 2.761; 95% CI, 1.257-6.067; P=0.011).ConclusionsAn elevated De Ritis ratio was significantly associated with worse prognosis in patients who underwent RC for urothelial BC. This ratio might further improve the predictive accuracy for prognosis in BC.
引用
收藏
页数:8
相关论文
共 30 条
[1]  
[Anonymous], EUR UROL
[2]   Complications and oncologic outcomes following robot-assisted radical cystectomy: What is the real benefit? [J].
Bak, Dong Jae ;
Lee, You Jin ;
Woo, Myeong Jin ;
Chung, Jae-Wook ;
Ha, Yun-Sok ;
Kim, Hyun Tae ;
Kim, Tae-Hwan ;
Yoo, Eun Sang ;
Kim, Bup Wan ;
Kwon, Tae Gyun .
INVESTIGATIVE AND CLINICAL UROLOGY, 2016, 57 (04) :260-267
[3]   The Preoperative AST/ALT (De Ritis) Ratio Represents a Poor Prognostic Factor in a Cohort of Patients with Nonmetastatic Renal Cell Carcinoma [J].
Bezan, Angelika ;
Mrsic, Edvin ;
Krieger, Daniel ;
Stojakovic, Tatjana ;
Pummer, Karl ;
Zigeuner, Richard ;
Hutterer, Georg C. ;
Pichler, Martin .
JOURNAL OF UROLOGY, 2015, 194 (01) :30-35
[4]  
CHANG SG, 1994, ANTICANCER RES, V14, P77
[5]   AN ENZYMIC TEST FOR THE DIAGNOSIS OF VIRAL HEPATITIS - THE TRANSAMINASE SERUM ACTIVITIES [J].
DERITIS, F ;
COLTORTI, M ;
GIUSTI, G .
CLINICA CHIMICA ACTA, 1957, 2 (01) :70-74
[6]   Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer [J].
Grossman, HB ;
Natale, RB ;
Tangen, CM ;
Speights, VO ;
Vogelzang, NJ ;
Trump, DL ;
White, RWD ;
Sarosdy, MF ;
Wood, DP ;
Raghavan, D ;
Crawford, ED .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (09) :859-866
[7]  
Ha Yun-Sok, 2016, [The Korean Journal of Urological Oncology, 대한비뇨기종양학술지], V14, P47
[8]   Tumorigenic and Prognostic Significance of RASSF1A Expression in Low-grade (WHO Grade 1 and Grade 2) Nonmuscle-invasive Bladder Cancer [J].
Ha, Yun-Sok ;
Jeong, Pildu ;
Kim, Ji Sang ;
Kwon, Whi-An ;
Kim, Isaac Yi ;
Yun, Seok-Joong ;
Kim, Gi-Young ;
Choi, Yung-Hyun ;
Moon, Sung-Kwon ;
Kim, Wun-Jae .
UROLOGY, 2012, 79 (06) :1411.e1-1411.e6
[9]   Prediction of Cancer Incidence and Mortality in Korea, 2016 [J].
Jung, Kyu-Won ;
Won, Young-Joo ;
Oh, Chang-Mo ;
Kong, Hyun-Joo ;
Cho, Hyunsoon ;
Lee, Jong-Keun ;
Lee, Duk Hyoung ;
Lee, Kang Hyun .
CANCER RESEARCH AND TREATMENT, 2016, 48 (02) :451-457
[10]   Bortezomib and dexamethasone for multiple myeloma: higher AST and LDH levels associated with a worse prognosis on overall survival [J].
Kiba, Takayoshi ;
Ito, Takuo ;
Nakashima, Toshihisa ;
Okikawa, Yoshiko ;
Kido, Miki ;
Kimura, Akiko ;
Kameda, Keita ;
Miyamae, Fumiaki ;
Tanaka, Suzuko ;
Atsumi, Misao ;
Sumitani, Yoko ;
Shitakubo, Yoshimi ;
Niimi, Hiromasa .
BMC CANCER, 2014, 14